BASF in spray drying co-operation with GEA Niro

Published: 11-Feb-2010 Featured companies: GEA Pharma and Healthcare
Manufacturing Ingredients Research & Development

BASF has signed an agreement with GEA Niro, which will allow BASF to make cGMP (current Good Manufacturing Practice) spray drying tests and pilot productions of active pharmaceutical ingredients (APIs) at GEA Niro\'s pharma test station in Copenhagen, Denmark.

BASF has signed an agreement with GEA Niro, which will allow BASF to make cGMP (current Good Manufacturing Practice) spray drying tests and pilot productions of active pharmaceutical ingredients (APIs) at GEA Niro's pharma test station in Copenhagen, Denmark. This test station is said to be one of the most advanced and versatile cGMP spray drying facilities worldwide.

Through the cooperation, BASF's Pharma Ingredients & Services division will add spray drying of APIs and formulations to its custom synthesis services for small molecules for the pharmaceutical industry.

Folker Ruchatz, BASF's director of global business management custom synthesis, said: "Teaming up with GEA Niro gives us access to a superior facility, and by working with the leading supplier of spray drying technology worldwide, we can provide the best solutions to our customers' needs sustainably."




Featured companies

GEA is a leading provider of process technology and packaging solutions for the pharmaceutical, biopharmaceutical, biotechnology and nutraceutical industries. Our portfolio...
  • Companies:
  • BASF Personal Care and Nutrition GmbH
See more

You may also like

Manufacturing

Continuous innovation: redefining the future of pharmaceutical manufacturing

Read more
In an industry in which reliability is paramount and change can be slow, GEA has consistently proven that innovation and stability go hand in hand. Almost two decades ago, GEA introduced the first ConsiGma® continuous manufacturing (CM) system to the pharmaceutical market — a pioneering move that helped to reshape how oral solid dosage (OSD) forms are developed and produced

Trending Articles

  1. Continuous innovation: redefining the future of pharmaceutical manufacturing In an industry in which reliability is paramount and change can be slow, GEA has consistently proven that innovation and stability go hand in hand. Almost two decades ago, GEA introduced the first ConsiGma® continuous manufacturing (CM) system to the pharmaceutical market — a pioneering move that helped to reshape how oral solid dosage (OSD) forms are developed and produced
  2. Abselion launches AAVX and AAV9 Total Capsid Quantification Kits Ready-to-use solution for Amperia benchtop platform supports rapid, reliable quantification across a range of serotypes
  3. diaago and Peak Analysis & Automation partner to bring practical automation solutions to research laboratories Using diaago's customer-first approach with PAA’s decades of expertise in laboratory robotics, the collaboration promises to deliver solutions to streamline workflows, boost throughput and reduce bottlenecks
  4. Suncombe and Kindeva collaborate to deliver low-carbon inhalers to the NHS The partnership will develop next-generation pressurised metered-dose inhalers with low Global Warming Potential propellants, helping the NHS move closer to its Net Zero target
  5. Douglas Pharmaceuticals sets new benchmark for capsule quality with CI Precision Partnership delivers compliance confidence, efficiency gains and reduced waste

Relevant companies

See more

Upcoming event

Enhancing probiotic stability through smarter formulation and packaging strategies

18 September 2025 | Virtual See all

You may also like

Manufacturing

Continuous innovation: redefining the future of pharmaceutical manufacturing

In an industry in which reliability is paramount and change can be slow, GEA has consistently proven that innovation and stability go hand in hand. Almost two decades ago, GEA introduced the first ConsiGma® continuous manufacturing (CM) system to the pharmaceutical market — a pioneering move that helped to reshape how oral solid dosage (OSD) forms are developed and produced
Manufacturing

Almac expands bioavailability capabilities to address a critical need in drug development

Almac Group has completed a multimillion-pound expansion of its bioavailability enhancement capabilities at its facility in Charnwood, UK
Manufacturing

Sustainability that performs: how GEA is building a better future for pharma

By embedding ESG principles into pharmaceutical manufacturing, GEA is delivering measurable sustainability performance without compromising compliance or productivity
Manufacturing

GEA raises guidance following strong H1 performance

Revised forecast reflects improved margins, robust order intake and efficiency gains
Manufacturing

First product chambers placed in GEA's "Factory of the Future"

Responding to the growing demand for freeze-drying systems, GEA Pharma & Healthcare is investing €80m in the construction of a pharmaceutical technology centre in Elsdorf (North Rhine-Westphalia)
Manufacturing

A forward-thinking approach to reducing downtime and costs in the pharmaceutical industry

Implementing predictive maintenance and a lifecycle package can significantly reduce both downtime and costs in the pharmaceutical industry, emphasises Benoit Dehaene from GEA Pharma & Healthcare
Ingredients

BASF opens US GMP Solution Centre in Michigan

Catered towards its biopharma and small molecule customers, the site will provide excipients and bioprocessing ingredients to the US market
Subscribe now